Thank you to Mark B. Pochapin, MD David Hudesman for all your leadership and support! Grateful to work with the best team 🙏🚀

Thank you Simon Hong for an excellent #GIGrandRounds on #IUS as an emerging key component of #IBD care. IUS…
▶️Is accurate & reliable for luminal inflammation & extraluminal complications
▶️Can predict short-term tx resp & long-term outcomes
▶️Can detect transmural healing

Join 🌟 faculty for ACG #IBD School & Eastern Régional PostGrad Course!

📌June 6-8, Washington DC

📲Register by May 7 for best rates gi.org

Sara Horst MD, MPH, FACG Arun Swaminath MD & Isabel Roitman NP Atoosa Rabiee & Reezwana C, MD, FACG Simon Hong Jordan Axelrad, MD, MPH David Choi, PharmD & al!

What an amazing opportunity to work alongside passionate colleagues at ACG #ACGAdvocacyDay2024 #ECLP advocating for the Safe Step Act and reducing Prior Authorizations - we need to reduce barriers for patients getting the care they need!💪🤝

Thankful for the opportunity to be a part of it!

I’m so honored to be advocating on behalf of our patients and our profession at #ACGAdvocacyDay2024 ACG#eclp

Thanks to everyone including our outstanding guest speakers Millie Long and Gil Y. Melmed, MD, MS for making #biggutIBD a HUGE success! 🙌🏼 NYU Langone Health Adam Faye MD MS Shannon Chang, MD David Hudesman Simon Hong Jordan Axelrad, MD, MPH Jessica Simon Andre Moreira Sophie Balzora, MD, FACG

Wrapping up #biggut NYU Langone Health with David Hudesman #DrLisaMalter - Thank you to all of our speakers (esp visiting profs Gil Y. Melmed, MD, MS Millie Long), sponsors and attendees 🙏 Catch us in 2025 for our 10th year of Big Gut IBD! 🙌

Updates on acute severe UC by Jordan Axelrad, MD, MPH at NYU Langone Health #biggutIBD ! CDI+ is a poor prognostic factor, inpatient IFX 5 mg/kg 🟰 10mg/kg, and JAKi are now an effective option (but can still use cyclo☝️)

Keynote lecture by Millie Long on the current status of precision 💊 in IBD NYU Langone Health #biggutibd

Some 🔑:
1️⃣ Profile UK: 🚫 utility of PredictSURE, but DID show benefit of early combo
2️⃣ Can use HLA-DQ A1*05, TPMT & NUDT15 to guide TNFa/IMM
3️⃣ TL1A’s (+ companion dx) on the way!

Amazing talk Sophie Balzora, MD, FACG on Social Determinants of Health in #IBD
🚨impact —> higher food insecurity, lower social support, increased hospitalization, lower used of advanced therapies- inclusion in RCTs
impt to move from equality —> equity ABGH David Hudesman

Surgery as first-line option in #IBD Shannon Chang, MD ✨
—> limited remission rates with current advanced therapies
—> 🚨delaying surgery when ultimately required can lead to inc AEs
Gil Y. Melmed, MD, MS Millie Long David Hudesman Sophie Balzora, MD, FACG Jordan Axelrad, MD, MPH Ariela Holmer Simon Hong

Giving an #IUS talking during an earthquake…that’s a first 😅

Dr. Lisa Malter presents the newer paradigm in the treatment pyramid for mod/severe #Crohns . Importantly, steroids are no longer included in the pyramid given its ADEs and use only in the short term. Undertreatment is also considered an ADE of sorts. Impt shift in mindset! #IBD

Kicking off NYU Langone Health Big Gut IBD 2024! Gil Y. Melmed, MD, MS reviews 1st-line 💉💊 for UC. Some highlights:
▶️ RCTs finally assessing proctitis and urgency
▶️ small molecules continue to show rapid onset of action
▶️ NO matter what you choose from
the “buffet” - monitor and T2T!

Starting NOW⌛️

Listen to a global leader in IBD
#VGIBDVP Combination IBD treatments - A to Z w/ Dr. Britta Siegmund 🇩🇪

Register 🔗 bit.ly/Global-IBD-VP-…

Florian Rieder Sara El Ouali MD Katie Falloon Steven D Wexner MD, PhD Taha Qazi Stefan Holubar MD MS Suha Abushamma, MD Cleveland Clinic Cleveland Clinic MD

Learning from our Peds colleagues! Nadia Ovchinsky, MD, MBA, FAASLD at NYU Langone Health GI Grand Rounds discussing IBAT (ileal bile acid transporter) inhibitors for cholestatic liver dz - now approved for 👧and promising early results for👨🏻

Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden by Shrestha et al. Jonas Halfvarson Tine Jess

academic.oup.com/ecco-jcc/advan…

Two more weeks to go! David Hudesman Adam Faye MD MS Ariela Holmer Simon Hong Jordan Axelrad, MD, MPH Brad Morganstern, MD

A pleasure to have #SidSingh from UC San Diego Health at IBD Grand Rounds NYU Langone Health give a very thought-provoking talk on treat-to-target
▶️ Endo remission is an aspirational goal, but given therapeutic ceiling of current 💊, how far do we push the envelope? 🤔